NCT05701839 is a NA clinical trial of face mask ventilation in Deep Sedation, sponsored by First Affiliated Hospital Xi'an Jiaotong University.

Who is sponsoring NCT05701839?

NCT05701839 is sponsored by First Affiliated Hospital Xi'an Jiaotong University.

What drugs are being tested in NCT05701839?

Interventions in NCT05701839: face mask ventilation, nasopharyngeal tube ventilation, oxygen saturation monitoring, oxygen reserve index monitoring.

What condition does NCT05701839 study?

NCT05701839 studies Deep Sedation.

Is NCT05701839 still recruiting?

NCT05701839 is currently status unknown. Last updated 1 February 2023.

Last reviewed 2023-02-01 · How we verify

NCT05701839

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Airway Management During Deep Sedation in Hysteroscopy

Status unknown NA Last updated 1 February 2023

What this trial tests

NA trial testing face mask ventilation in Deep Sedation in 400 participants. Status unknown.

Timeline

1 February 2023

Primary endpoint
30 November 2023

30 November 2024

Quick facts

Lead sponsor	First Affiliated Hospital Xi'an Jiaotong University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	400
Start date	1 February 2023
Primary completion	30 November 2023
Estimated completion	30 November 2024
Sites	1 location across China

Drugs / interventions tested

face mask ventilation
nasopharyngeal tube ventilation
oxygen saturation monitoring
oxygen reserve index monitoring

Conditions studied

Deep Sedation — all drugs for Deep Sedation →

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Who can join

Adults 18 to 60, female only, with Deep Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hysteroscopy is used to examine and treat uterine diseases. Because of severe pain due to uterine distention and cervical dilatation, deep sedation usually be provided during this procedure. Respiratory depression and upper airway obstruction are main respiratory complications during deep sedation. Face mask and nasopharyngeal airway are main airway management during deep sedation. Oxygen reserve index is a non-invasive parameter, it reflects the moderate hyperoxia statues. In this study, investigators compare the effect of face mask and nasopharyngeal airway management on oxygenation during deep sedation in participants undergoing hysteroscopy. Investigators also investigate whether oxygen reserve index monitoring reduce the incidence of hypoxemia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Oxygen reserve index monitoring reduced the incidence of low pulse oxygen saturation during deep sedation for hysteroscopy: a prospective randomized controlled trial.
Guan Z, Li X, Liu L, Liu J, et al · · 2026 · PMID 41788712 · DOI 10.3389/fmed.2026.1732543

Verify or expand the search:

Other First Affiliated Hospital Xi'an Jiaotong University trials

Trials by the same sponsor.

NCT07389460 — Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) · Phase 3 · not yet recruiting
NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
NCT07168291 — Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma · EARLY_PHASE1 · not yet recruiting
NCT06775782 — Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis · NA · recruiting
NCT07266467 — Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Dis · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05701839 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital Xi'an Jiaotong University
Last refreshed: 1 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05701839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing